$Regenxbio (RGNX.US)$ on 07 Feb will provide an interim clin...
$Regenxbio(RGNX.US$ on 07 Feb will provide an interim clinical study update of RHX121 for treatment of neuropathic mucopolysaccharaidosis.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
